Q1 2023 Holdings
Filed 2023-05-15 | 72 holdings | $242.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Fresh Tracks Therapeutics Inc | EQUITIES | 10802T204 | $6.6K | 10,000 | 0.0% |
| Rocket Pharmaceuticals Inc | WARRANTS | 77313F114 | $11.5K | 104,828 | 0.0% |
| Eloxx Pharmaceuticals Inc(ELOXUSD) | EQUITIES | 29014R202 | $135.7K | 54,075 | 0.1% |
| Compugen Ltd(CGEN) | EQUITIES | M25722105 | $231.8K | 330,188 | 0.1% |
| Lava Therapeutics NV | EQUITIES | N51517105 | $232.9K | 140,291 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | EQUITIES | 61225M102 | $242.7K | 31,156 | 0.1% |
| Cvrx Inc(CVRX) | EQUITIES | 126638105 | $279.6K | 30,000 | 0.1% |
| Aligos Therapeutics Inc | EQUITIES | 01626L105 | $552.3K | 631,887 | 0.2% |
| Tela Bio Inc(TELA) | EQUITIES | 872381108 | $575.6K | 54,096 | 0.2% |
| ImmunoGen Inc(IMGNEUR) | EQUITIES | 45253H101 | $576.0K | 150,000 | 0.2% |
| Acumen Pharmaceuticals Inc(ABOS) | EQUITIES | 00509G209 | $596.5K | 146,922 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | EQUITIES | 10806X102 | $663.2K | 40,000 | 0.3% |
| Jasper Therapeutics Inc | EQUITIES | 471871103 | $905.0K | 500,000 | 0.4% |
| Viridian Therapeutics Inc(VRDN) | EQUITIES | 92790C104 | $925.5K | 36,381 | 0.4% |
| Allakos Inc(ALLKGUSD) | EQUITIES | 01671P100 | $939.0K | 211,010 | 0.4% |
| Cue Biopharma Inc(CUE) | EQUITIES | 22978P106 | $1.1M | 306,278 | 0.5% |
| Astria Therapeutics Inc(CATBUSD) | EQUITIES | 04635X102 | $1.2M | 93,823 | 0.5% |
| Sarepta Therapeutics Inc(SRPT) | EQUITIES | 803607100 | $1.3M | 9,270 | 0.5% |
| Seres Therapeutics Inc(MCRB1EUR) | EQUITIES | 81750R102 | $1.3M | 232,525 | 0.5% |
| Eliem Therapeutics Inc(CLYM) | EQUITIES | 28658R106 | $1.4M | 485,955 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | EQUITIES | 45826J105 | $1.4M | 37,858 | 0.6% |
| Phathom Pharmaceuticals Inc(PHAT) | EQUITIES | 71722W107 | $1.4M | 200,000 | 0.6% |
| Point Biopharma Global Inc | EQUITIES | 730541109 | $1.4M | 198,477 | 0.6% |
| Prometheus Biosciences Inc | EQUITIES | 74349U108 | $1.5M | 13,921 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | EQUITIES | 89532M101 | $1.6M | 885,924 | 0.7% |
| Altimmune, Inc(ALT)Call | LONG OPTION CALLS | 02155H200 | $1.8M | 415,700 | 0.7% |
| Aclaris Therapeutics Inc(ACRS) | EQUITIES | 00461U105 | $1.8M | 220,100 | 0.7% |
| Morphic Holding Inc | EQUITIES | 61775R105 | $1.9M | 51,684 | 0.8% |
| Immatics Nv(IMTX) | EQUITIES | N44445109 | $1.9M | 282,432 | 0.8% |
| Mersana Therapeutics Inc | EQUITIES | 59045L106 | $2.2M | 540,059 | 0.9% |
| MoonLake Immunotherapeutics(MLTX) | EQUITIES | 61559X104 | $2.3M | 105,750 | 0.9% |
| Ventyx Biosciences Inc(VTYX) | EQUITIES | 92332V107 | $2.3M | 70,000 | 1.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | EQUITIES | 558868105 | $2.4M | 10,000 | 1.0% |
| Protagonist Therapeutics Inc(PTGX) | EQUITIES | 74366E102 | $2.4M | 105,486 | 1.0% |
| Insmed Inc(INSM) | EQUITIES | 457669307 | $2.5M | 143,794 | 1.0% |
| Incyte Corp(INCY) | EQUITIES | 45337C102 | $2.5M | 33,938 | 1.0% |
| Mirum Pharmaceuticals Inc(MIRM) | EQUITIES | 604749101 | $2.5M | 105,939 | 1.1% |
| Pliant Therapeutics Inc(PLRX) | EQUITIES | 729139105 | $2.7M | 100,000 | 1.1% |
| Cullinan Oncology Inc(CGEM) | EQUITIES | 230031106 | $2.7M | 265,032 | 1.1% |
| Krystal Biotech Inc(KRYS) | EQUITIES | 501147102 | $2.7M | 34,014 | 1.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | EQUITIES | 02043Q107 | $2.8M | 14,043 | 1.2% |
| Celldex Therapeutics Inc(CLDX) | EQUITIES | 15117B202 | $3.0M | 84,651 | 1.3% |
| 89bio, Inc(ETNBGBP)Call | LONG OPTION CALLS | 282559103 | $3.0M | 200,000 | 1.3% |
| Biogen Idec Inc(BIIB) | EQUITIES | 09062X103 | $3.1M | 11,311 | 1.3% |
| Cerus Corp(CERS) | EQUITIES | 157085101 | $3.4M | 1,152,902 | 1.4% |
| Xenon Pharmaceuticals Inc(XENE) | EQUITIES | 98420N105 | $3.5M | 96,643 | 1.4% |
| Regeneron Pharmaceuticals Inc(REGN) | EQUITIES | 75886F107 | $4.1M | 5,000 | 1.7% |
| Vertex Pharmaceuticals Inc(VRTX) | EQUITIES | 92532F100 | $4.2M | 13,181 | 1.7% |
| United Therapeutics Corp(UTHR) | EQUITIES | 91307C102 | $4.2M | 18,578 | 1.7% |
| ImmunoGen, Inc(IMGNEUR)Call | LONG OPTION CALLS | 45253H101 | $4.3M | 1,128,200 | 1.8% |